Macular degeneration trials in Bulgaria

3 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

  Where

  Sofiya

  Age

  50 years and over

  People

  272 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07441642 · EU 2025-523704-77-00
• Phase 3Taking people
  Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

  Where

  Burgas, Plovdiv, Sofia, Stara Zagora

  Age

  50 years and over

  People

  561 worldwide

  Run by

  AbbVie

  See details and how to joinNCT07007065 · EU 2024-512298-28-00
• Phase 3Active, not recruiting
  Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  Where

  Sofia

  Age

  50 years and over

  People

  480 worldwide

  Run by

  4D Molecular Therapeutics

  See details and how to joinNCT07064759